Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in ...

AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

The US Food and Drug Administration’s independent vaccine advisers voted Thursday in favor of recommending approval of a new vaccine to protect infants from respiratory syncytial virus, known as ...

It's called human metapneumovirus (HMPV). "The symptoms are identical almost to influenza and respiratory syncytial virus," said Dr. Jorge Rodriguez, a board-certified internal medicine specialist.

Study shows key role for human T cells in the control of Respiratory Syncytial Virus (RSV) infection Date: May 24, 2023 Source: University of North Carolina Health Care Summary: A new study has ...

Health officials reported that cases of human metapneumovirus (HMPV) spiked this spring as COVID-19 and Respiratory Syncytial Virus cases fell. National data from the Centers for Disease Control ...

Cases of human metapneumovirus or HMPV, a common but lesser-known respiratory virus, surged in the U.S. this spring. Here's what to know about symptoms and transmission.

WHAT WE FOUND Human Metapneumovirus (HMPV) is not new. The respiratory virus was first identified in 2001, according to the Centers for Disease Control and Prevention.

Yes, folks, 2023 saw yet another case of a respiratory virus surging beyond what it normally does. The influenza and respiratory syncytial viruses spiked much higher this winter than in previous ...

In China, HMPV ranked eighth among the eight viruses that cause acute respiratory infections, with a positive rate of 4.1 percent, which is far lower than the 28.5 percent rate of the influenza virus.